Skip to Content
Find More Like This
Return to Search

Nucleic acids encoding human trithorax protein

United States Patent

6,175,000
January 16, 2001
View the Complete Patent at the US Patent & Trademark Office
In accordance with the present invention, there is provided an isolated peptide having the characteristics of human trithorax protein (as well as DNA encoding same, antisense DNA derived therefrom and antagonists therefor). The invention peptide is characterized by having a DNA binding domain comprising multiple zinc fingers and at least 40% amino acid identity with respect to the DNA binding domain of Drosophila trithorax protein and at least 70% conserved sequence with respect to the DNA binding domain of Drosophila trithorax protein, and wherein said peptide is encoded by a gene located at chromosome 11 of the human genome at q23. Also provided are methods for the treatment of subject(s) suffering from immunodeficiency, developmental abnormality, inherited disease, or cancer by administering to said subject a therapeutically effective amount of one of the above-described agents (i.e., peptide, antagonist therefor, DNA encoding said peptide or antisense DNA derived therefrom). Also provided is a method for the diagnosis, in a subject, of immunodeficiency, developmental abnormality, inherited disease, or cancer associated with disruption of chromosome 11 at q23.
Evans; Glen A. (Encinitas, CA), Djabali; Malek (Marseilles, FR), Selleri; Licia (Del Mar, CA), Parry; Pauline (San Diego, CA)
The Salk Institute for Biological Studies (La Jolla, CA)
08/ 061,376
May 13, 1993
ACKNOWLEDGEMENT This invention was made with Government support under Grant No. HG00202, awarded by the National Institutes of Health and Grant No. DE-FG03-88ER60694/A6, awarded by the Department of Energy. The Government may have certain rights in the invention.